Pfizer will study the effectiveness of its vaccine against COVID-19 by inoculating the whole population over the age of 12 in a town in southern Brazil, the company said on Wednesday.
The study will be conducted in Toledo, population 143,000, in the west of Parana state, together with Brazil's National Vaccination Program, local health authorities, a hospital and the federal university.
Pfizer said the purpose was to study the behaviour of COVID-19 in a "real life scenario" after the population has been vaccinated.
"The initiative is the first and only of its kind to be undertaken in a developing country in collaboration with the pharmaceutical company," it added.
Trump says US needs to own Greenland to deter Russia, China
Kyiv scrambles to repair ruined power grid after Russian attack
Swiss prosecutors summon owners of ski resort bar after deadly blaze
Death toll in Philippines landfill collapse rises to 4
Australian bushfires raze homes, cut power to tens of thousands
